Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

WGA strike to end
Found guilty of killing mom
Newsom signs gun laws
Earth's next supercontinent
PFAS harming wildlife?
Brooks Robinson dies at 86
Settles Epstein lawsuit
Focusing on fall prevention
Academy to replace Oscar
Condemns body shaming
Messi injury update
Votes to advance funding bill
RU commander still alive?
Debate candidates revealed
Iraq wedding fire kills 100
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
1,150 results
18m
Drug companies urging FDA to block Florida prescription imports
The Food and Drug Administration is expected to soon decide if Florida can import cheaper prescription drugs from Canadian ...
Atlanta Journal-Constitution1mon
Cancer drug shortage prompts Georgia lawmakers to raise issue with FDA
The FDA subsequently allowed imports of the cancer drug from China, from Qilu Pharmaceutical, whose version of the drug is unapproved in the U.S. Georgia’s elected officials are asking the FDA ...
Scientific American
8d
Why There’s a Serious Cancer Drug Shortage, and How to Fix It
A cancer diagnosis is already devastating. It’s even more gut-wrenching when your doctor tells you that a drug shortage has ...
PMLiVE11d
FDA boosts collaboration with manufacturers to overcome ongoing cancer drug shortages
The US Food and Drug Administration (FDA) has increased its collaboration with cancer drug manufacturers in a bid to overcome the country’s ongoing drug shortage problem and reduce impacts on patients ...
STAT1d
FDA panel votes against GLP-1 therapy from former diabetes unicorn Intarcia
An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said ...
Yahoo Finance11d
Iovance (IOVA) Up Despite FDA's Delayed Decision on Melanoma Drug
Iovance Biotherapeutics IOVA announced that the FDA has postponed the previously expected decision date, regarding the company’s biologics license application (BLA) for lifileucel, from Nov 25 ...
Everyday Health7d
FDA Approves Momelotinib (Ojjaara) for Myelofibrosis Patients With Anemia
The U.S. Food and Drug Administration (FDA) has approved the first drug in a family of medicines known as JAK inhibitors that can treat myelofibrosis patients with anemia. Momelotinib (Ojjaara) is ...
MM&M6d
FDA grants priority review to Keytruda combo therapy for cervical cancer
The Food and Drug Administration granted Merck a priority review for its application for Keytruda in combination with concurrent chemoradiotherapy, the company announced Wednesday. According to Merck, ...
Mena FN15d
Biosyngen Received Fda Approval For Phase I/Ii Clinical Trials For Brl03, Targeting Lung Cancer, Gastric Cancer And Other Advanced Solid Tumors
(MENAFN- PR Newswire) SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- On September 9th, 2023, Biosyngen Pte Ltd (hereafter as "Biosyngen") announced that the U.S. FDA has cleared the Investigational New ...
The Boston Globe4d
FDA advisory panel rejects drug-device combination to treat Type 2 diabetes
A panel of medical advisers on Thursday unanimously dashed a Cambridge biotech’s hopes that US regulators would reconsider a twice-rejected implantable device designed for adults with ...
Atlanta Journal-Constitution26d
Capitol Recap: Georgia lawmakers want answers about shortage of cancer drugs
A bipartisan share of Georgia’s congressional delegation is pressing the Food and Drug Administration for information about what it’s doing to ease a shortage of cancer drugs. The shortage ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices